JTR  Vol.4 No.1 , March 2016
Human Immunodeficiency Virus and Immunological Profiles among Suspected Tuberculosis Cases in Mombasa County, Kenya
Abstract: Background: Human immunodeficiency virus (HIV) is a major public health concern and cause of death globally including Kenya. HIV infection is characterised by CD4+ lymphocyte depletion manifested through the loss of the immune response capacity. Aim: This study aimed to determine the prevalence of HIV infection and CD4+T cell counts among suspected tuberculosis (TB) cases seeking healthcare at TB clinics in Mombasa County, Kenya. Study Design: Hospital and laboratory based cross-sectional study was carried between May 2011 and November 2013 in Coast General Referral Hospital, Tudor, Port-Reitz, Mlaleo, Likoni and Mikandani districts and sub-districts hospitals. Methodology: A total of 500 suspected TB cases (271 males and 229 females) were screened for HIV infection using Trinity Biotech Uni-GoldTM test and positives confirmed with the enzyme- linked immunosorbent assay. CD4+ and CD8+T cells were analyzed using a BD FACS Count flow cytometer. A questionnaire was used to collect demographic data of the participants. Results: In total, 127 (25.4%) of the suspects were HIV infected 55.1% females and 44.9% males. Females were significantly affected than males (OR = 0.78; 95% CI: 0.44 - 1.37; p = 0.042). The majority (36.2%) of the HIV cases were in the 25 - 34 years age group followed by the 35 - 44 (33.9%), 45 - 54 (16.5%) and 18 - 24 (7.1%) age groups, respectively. Widowed (AOR = 6.14; 95% CI: 1.53 - 20.54; p < 0.033), alcohol (AOR = 2.83; 95% CI: 1.71 - 4.87; p < 0.001) and condom use (AOR = 2.31; 95% CI: 1.62 = 4.71; p < 0.002) were risk factors associated with HIV infection. The mean CD4 cell count was 333.27 ± 150.59 cells/mm3 and it was higher in males (343.05 ± 149.33 cells/mm3) than females (325.93 ± 152.92 cells). The mean values of white blood cells (5.9 ± 2.42) × 109/l), packed cell value (34.1% ± 4.3%), platelets (195.16 ± 88.7) × 109/l and erythrocyte sedimentation rate (102.0 ± 17.4 mm/hr) were significantly lower than the control group (p < 0.05). Conclusion: The prevalence of HIV infection among suspected TB cases was 25.4% which was higher than the current national average HIV prevalence of 6.9%. Lower CD4+ lymphocyte count was found to be the only predicting factor for HIV. There was a significant relationship between CD4/ESR and HIV infection.
Cite this paper: Yonge, S. , Otieno, M. , Sharma, R. , Nteka, S. (2016) Human Immunodeficiency Virus and Immunological Profiles among Suspected Tuberculosis Cases in Mombasa County, Kenya. Journal of Tuberculosis Research, 4, 34-45. doi: 10.4236/jtr.2016.41005.

[1]   Stover, J., Brown, T. and Marston, M. (2012) Updates to the Specrtrum/Estimation and Projection Package (EPP) Model to Estimate HIV Trends for Adults and Children. Sexually Transmitted Infections, 88, 11-16.

[2]   Aderaye, G. (2007) Pulmonary TB and Pneumocystis Jeroveci Pneumonia in HIV in HIV Infected Patients in Ethopia.

[3]   WHO (2013) Global Tuberculosis Control, Surveillance, Planning and Financing: WHO Report, WHO/HTM/TB, World Health Organization, Geneva, 349.

[4]   Nyamogoba, H., Mbuthia, G. and Obel, M. (2011) A High Rate of Human Immodeficiency Virus Infection among Suspected Tuberculosis Cases in Western Kenya. African Journal of Health Sciences, 19, 36-40.

[5]   Delany, M.S., Bello, B., Kinross, P., et al. (2013) HIV Prevalence and Risk in Long-Distance Truck Drivers in South Africa: A National Cross-Sectional Survey. International Journal of STD & AIDS, 25, 428-438.

[6]   United Nations & AIDS (UNAIDS) (2013) Accelerating Action against AIDS in Africa. Geneva, Switzerland.

[7]   National AIDS Control Council (NACC) (2013) Global Facts and Figures: The Global AIDS Epidemic.

[8]   Agot, K.E., Vandor, S., Tracy, M., Obare, B.A., Bukusi, E.A., et al. (2010) Widow Inheritance and HIV Prevalence in Bondo District, Kenya: Baseline Results from Prospective Cohort Study. PLoS ONE, 5, e14028.

[9]   National AIDS Control Council (NACC) and National AIDS and STD Control Programmme (2012) Estimates and Interim Projected HIV Prevalence and Incidence and Trends for 2008-2015.

[10]   National AIDS Control Program, Ministry of Medical Services, Government of Kenya (2013) Scale up of Access to ART in Kenya.

[11]   National AIDS and STD Control Programme. Ministry of Medical Services, Government of Kenya (2013) Scale up of Access to ART in Kenya.

[12]   Sanders, E.J., Grahamc, S.M., Okuku, H.S., Van der Elst, E.M., Muhari, A., Davies, A., Peshu, N., et al. (2007) HIV-1 Infection in High Risk Men Who Have Sex with Men in Mombasa, Kenya. AIDS, 21, 2513-2520.

[13]   Jones, B., Young, S.M., Antoniskis, D., Davidson, P., Kramer, F. and Barnes, P. (1993) Relationship of the Manifestations of Tuberculosis to CD4 Cell Counts in Patient with Human Immunedefficiency Virus Infections. American Review of Respiratory Disease, 148, 1292-1297.

[14]   Miaini, M.K., Gilson, R.J.C., Chavada, N., Gill, S., Fakayo, A., Ross, E.J., Philips, A.N. and Weller, I.V.D. (1996) Reference Ranges and Sources of Variability of CD4 Counts in HIV-Seronegative Women and Men. Journal of Genitourinary Medicine, 72, 27-31.

[15]   Uppas, S., Verma, S., Dhot, P., et al. (2005) Normal Values of CD4 and CD8 Lymphoctes Subsets in Healthy Indian Adults and the Effects of Sex, Age Gender and Smoking. Cytometry Part B: Clinical Cytometry, 52, 32-36.

[16]   Mientjes, G.H., Ameijden, E.J., Roos, M.T., Leeuw, N.A., Coutinho, R.A. and Miedema, F. (1992) Large Diurnal Variation in CD4 Cell Count and T-Cell Function among Drug Users: Implications for Clinical Practice and Epidemiological Studies. AIDS, 6, 1269-1272.

[17]   Shahabbuddin, S. (1995) Quatitative Differences in CD8+ Lymphocytes, CD4/CD8 Ratio, NK Cells and HLA-DR (+)-Activated T Cells of Racially Different Male Populations. Clinical Immunology and Immunopathology, 75, 168- 170.

[18]   Prins, M., Robertson, J.R., Brettle, R.P., Aguado, H., Broers, B., Boufassa, F., Goldberg, D.J., Zangerle, R., Coutinho, R.A. and van den Hoek, A. (1999) Do Gender Differences in CD4 Cell Counts Matter? AIDS, 13, 2361-2364.

[19]   Jannosy, G. and Golide, W. (2000) Affordable CD4 T-Cells Count on Single Platform Flow Cytometers. CD4 Gating. Brazil Journal of Haematology, 111, 1198-1208.

[20]   Lawson, L., Yassin, M., Thatcher, T., et al. (2008) Clinical Presentation of Adults with Pulmonary Tuberculosis with and without HIV Infection in Nigeria. Scandinavian Journal of Infectious Diseases, 40, 30-35.

[21]   Cohen, B. and Trussel, J. (2006) Preventing and Mitigating AIDS in Sub-Saharan Africa: Research and Data Priorities for the Social Behavioural Sciences. The National Academy press, Washington DC.

[22]   Trinity Biotech (2008) Uni-GoldTMHIV Insert.

[23]   Abbot Murex, Murex Biotech Limited, the United Kingdom (2007) Murex HIV Ag/Ab Combination Insert.

[24]   Daley, C., Small, P., Scheeter, G., School Link, G., McAdam, R., Jacobs, W. and Hopewell, P. (1992) An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with Human Immunodeficiency Virus—An Analysis Using Restriction-Fragment-Length Polymorphism. New England Journal of Medicine, 326, 231-235.

[25]   Brenan, C.A., Bodelle, P., Coffey, R., et al. (2008). The Prevalence of Diverse HIV-1 Strains Was Stable in Cameroonian Blood Donors from 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 49, 432-439.

[26]   Nyobi, B.M., Kristiansen, K.I., Bjune, G., Müller, F. and Holm-Hansen, C. (2008) Diversity of Human Immunodeficiency Type 1 Subtype in Kegera and Kilimanjaro Regions, Tanzania. AIDS Research and Human Retroviruses, 24, 761-769.

[27]   Zacharia, R., Fitzgerald, M., Massaquoi, M., Acabu, A., Chilomo, D., Salaniponi, F. and Harries, A.D. (2008) Does Antiretroviral Treatment Reduce Case Fatality among HIV-Positive Patients with Tuberculosis in Malawi? International Journal of Tuberculosis and Lung Disease, 11, 848-853.

[28]   Jemikalajah, J. and Okogun, G. (2009) Health Point Prevalence of HIV and Pulmonary Tuberculosis among Patients in Various Parts of Delta State. Nigeria. Saudi Medical Journal, 30, 387-391.

[29]   Matee, M., Mtei, L., Lounasvaara, T., Weiland-Alter, W., Waddell, R., Lyimo, J., Bkari, M., Pallangyo, K. and Von, C. (2008) Sputum Microscopy for Diagnosis of HIV-Associated Pulmonary Tuberculosis in Tanzania. BMC Public Health, 8, 68-72.

[30]   Kalichman, S.C., Simbavi, L.C., Kaufman, M., Cain, D., Jooste, S., et al. (2007) Alcohol Use and Sexual Risks for HIV/AIDS in Sub-Saharan Africa: Systematic Review of Empirical Findings. Prevention Science, 8, 141-151.

[31]   Murill, C.S., Prevots, D.R., Miller, M.S., Linely, L.A., Royalty, J.E., Gwinn, M., et al. (2001) Incidence of HIV among Injection Drug Users Entering Drug Treatment Programs in Four US Cities. Journal of Urban Health, 78, 152-161.

[32]   Tarbasi, P., Mirasaeidi, M., Amiri, M., Mansouri, D., Masjedi, M., Velayati, A., et al. (2008) Clinical and Laboratory Profile of Patients with Tuberculosis/Co-Infection at a National Referral Centre: A Case Series. National Research Institute of Tuberculosis and Lung Diseases, Tehran.

[33]   Tegbaruet, B., Messele, T., Hailu, E., Girma, M., Demissie, et al. (2001) Clinical Outcomes and Laboratory Results of Tuberculosis Patients with or without HIV Infection in Two Health Institutions in Addis Ababa Ethiopian Health and Nutrition Research Institute.

[34]   Affussimet, C., Kesieme, E. and Abah, V. (2011) The Pattern of Presentation of Tuberculosis in HIV Seropositive Patients Seen at Benin City, Nigeria. Ambrose Alli University, Ekpoma.

[35]   Nwachukwu, E. and Peter, G. (2010) Prevalence of Mycobacterium tuberculosis and Human Immmunodefiency Virus (HIV) Infections in Umuahia, Abia State, Nigeria. African Journal of Microbiology Research, 14, 1486-1490.

[36]   Kusar, M., Koch, M., Mittrucker, W., Nouailles, G., Bonhagen, K., Kamradt, T. and Kauffman, H. (2007) Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis. Journal of Immunology, 178, 2661-2665.

[37]   Moore, D., Liechty, C., Palacious, E., et al. (2007) Prevalence, Incidence and Mortality Associated with Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Uganda. AIDS, 12, 713-719.

[38]   Onubogu, C., Kunle-Ope, C., Onyejepu, N., Nwokoye, N.N., Raheem, et al. (2010) Prevalence of Tuberculosis and Human Immunodeficiency Virus (TB/HIV) Co-Infections amongst Patients with Bronchopulmonary Disorders in Lagos. African Journal of Microbiology Research, 7, 1904-1908.

[39]   Ministry of Health, Kenya. (2013) National Leprosy and Tuberculosis Control Programme (NLTP). Annual Report.

[40]   Ngowi, B.J., Mfinanga, S.G., Bruun, J.N and Morkve, O. (2009) Pulmonary Tuberculosis among People Living with HIVAIDS Attending Care and Treatment in Rural Northern Tanzania. BMC Public Health, 8, 341.

[41]   Mmbanga, E.J, Hussein, A., Leyna, G.H., Mnyika, K.S., Sam, N.E., Klepp, K.I. et al. (2007) Prevalence and Risk factors for HIV-1 Infection in Rural Kilimanjaro Region of Tanzania: Implications for Prevention and Treatment. BMC Public Health, 7, 58.

[42]   Ibeneme, E.O., Asuquo, A.E and Abia-Bassey, L.N. (2009) Prevalence of Pulmonary Tuberculosis and HIV Co-Infection among Prisoners in Calabar, Nigeria. Mary Slessor Journal of Medicine, 9, 198-203.